The mTOR signaling pathway as a treatment target for intracranial neoplasms - Wikidata - awgldk - TriplyDB

The mTOR signaling pathway as a treatment target for intracranial neoplasms

The mTOR signaling pathway as a treatment target for intracranial neoplasms

http://www.wikidata.org/entity/Q34886859

about

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition.Treating recurrent glioblastoma: an update.Inhibiting 4EBP1 in glioblastoma.mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.mTOR-Dependent Cell Proliferation in the Brain.A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913.[Hereditary tumor syndromes in neuropathology].

P2860

Q28079501-EBF27A6E-4002-4F09-B2E7-35675F197869 Q36278102-959DB2E9-73FF-47E2-996B-376D6A70D71A Q36379857-3D6E856D-AF2C-4D06-B1A5-E496E137097D Q36875981-3CC72176-7957-492F-80A9-8E5E5A6851D5 Q37362875-FE4D1E07-32F6-4369-869D-EA613AB99437 Q38376610-393C99C4-BB5A-41CF-864A-89422659B7C0 Q38659417-15A49F16-772F-4F40-A8DB-3A1B2D28EE0A Q38794065-44EA40F5-5BAD-436A-88D8-718446917905 Q47231432-F9C020A6-A3FC-4B34-B228-7A04E5861EDD Q50068283-B5C02ADB-84FA-4063-91B0-77DFB036962D Q53312284-B081FD62-5F04-47DC-AFCD-38A559396F59

P2860

The mTOR signaling pathway as a treatment target for intracranial neoplasms

http://www.wikidata.org/entity/Q34886859

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@ast

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@en

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@nl

type

label

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@ast

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@en

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@nl

prefLabel

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@ast

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@en

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@nl

P1433

Q34886859-C3913F64-EF56-4548-B547-7FAFA17FA013

P1476

Q34886859-925E7AE1-5576-4F44-BEAA-268EB54745D6

P2093

Q34886859-3B22BCC0-F17A-44B0-A8FE-CD9FD1C09FC6

Q34886859-EF15A2CA-580A-49A0-A4E2-74A948E184D2

Q34886859-FDCFC61A-9C90-43B9-ACAF-F71D0C073250

P2860

Q34886859-000F74EF-1C48-4830-BE14-B61A30D88E45

Q34886859-0048E1D9-F44E-4676-9D45-015AFAFBE7C2

Q34886859-0345F78C-F3ED-4E4A-847D-FFA0E165CA22

Q34886859-062D113B-609C-4BBC-A736-3E8817FC5B76

Q34886859-098D1F90-D0C4-495E-B525-49ABE4FFC96D

Q34886859-0E980B0F-D26F-4E3C-8271-A8FD203AF5F8

Q34886859-10BC2BDC-4159-4A1D-B12A-4355B0749863

Q34886859-1167BCB6-1538-4163-8755-0A0DCFE3319A

Q34886859-16409FF7-836D-4D38-B7F4-E94AAABB5FD1

Q34886859-16643D60-A962-4C37-B1D1-606C22DD4FEC

P304

Q34886859-AE84A589-2B16-4721-974C-A64DDDBD52F4

P31

Q34886859-21DD386E-C01E-4898-A5C4-F794A103DE26

P356

Q34886859-4D8D3D49-A4A3-429E-8E41-9C6751A9E14C

P433

Q34886859-24EAF572-4A0F-4235-AC61-FEDCC329CEF1

P478

Q34886859-ADFC450D-B569-4CA0-A908-7046CED08459

P50

Q34886859-C81B16F3-6146-48FA-AE12-303325737BA6

P577

Q34886859-A7A1E6BE-2181-473C-9703-CAA285A0D3E9

P5875

Q34886859-EE22212F-F99B-4458-9AF9-CFB4E50330AC

P698

Q34886859-A2B7C764-7202-4C26-AEFB-548FEA9912F8

P932

Q34886859-63CD1922-7C0D-4E9B-A92B-53103C0BDF68

P356

P1433

P1476

The mTOR signaling pathway as a treatment target for intracranial neoplasms

@en

P2093

Christian Mawrin

http://www.w3.org/2001/XMLSchema#string

David H Gutmann

http://www.w3.org/2001/XMLSchema#string

Doreen Pachow

http://www.w3.org/2001/XMLSchema#string

P2860

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients

Activation of mTORC2 by association with the ribosome

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling

P304

189-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOU164

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265133799

http://www.w3.org/2001/XMLSchema#string

P698

25165193

http://www.w3.org/2001/XMLSchema#string

P932

4288522

http://www.w3.org/2001/XMLSchema#string